Specifically, EZH2 is significantly overexpressed in MDS and AML primary tumor cells that display aberrant DNA methylation of the gene encoding the tumor suppressor p15INK4B compared with tumors where p15INK4B is not methylated [51]. Here, CDKN2B is linked to myelodysplastic syndrome.